Prevention of Female Cancers by Optimization of Selenium Levels in the Organism.

NAUnknownINTERVENTIONAL
Enrollment

7,000

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Breast Neoplasms
Interventions
DIETARY_SUPPLEMENT

Selenium supplementation or placebo treatment

Patients from this group will receive selenium supplement to achieve optimal selenium level

OTHER

Diet modification

Patients from this group will have modified diet over the course of the study. Diet modification is aimed to lower selenium concentration in blood.

OTHER

Selenium supplementation or placebo treatment and diet modification

In this group patients will receive supplement, placebo or diet modification. The goal is to raise selenium concentration in blood

Trial Locations (1)

72-003

Read-Gene S.A., Grzepnica

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Center for Research and Development, Poland

OTHER

collaborator

IQ Pharma S.A.

UNKNOWN

collaborator

West Pomeranian University of Technology

UNKNOWN

collaborator

Vipharm S.A.

UNKNOWN

lead

Read-Gene S.A.

OTHER

NCT04014283 - Prevention of Female Cancers by Optimization of Selenium Levels in the Organism. | Biotech Hunter | Biotech Hunter